Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Mildvan

Showing results (41-50 of 86) with videos related to

Pageof 9
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 1, 1995
Predictors and outcome of multidrug-resistant tuberculosisN Salomon, D C Perlman, P Friedmann, et al.
Ophthalmology|July 1, 1987
Combined short- and long-term therapy for the treatment of cytomegalovirus retinitis using ganciclovir (BW B759U)J Orellana, S A Teich, A H Friedman, et al.
The New England Journal of Medicine|May 29, 1986
Toxic keratopathy associated with suramin therapyS A Teich, S Handwerger, U Mathur-Wagh, et al.
Journal of Clinical Immunology|March 1, 1997
Concentrations of soluble CD95 and CD8 antigens in the plasma and levels of CD8+CD95+, CD8+CD38+, and CD4+CD95+ T cells are markers for HIV-1 infection and clinical statusJ D Jiang, M Schlesinger, H Sacks, et al.
Lancet (London, England)|February 11, 1984
Iron and iron binding proteins in persistent generalised lymphadenopathy and AIDSB S Blumberg, H W Hann, D Mildvan, et al.
Lancet (London, England)|July 2, 1983
Increased frequency of HLA-DR5 in lymphadenopathy stage of AIDSR W Enlow, A Nunez Roldan, P LoGalbo, et al.
The American Journal of Medicine|August 1, 1987
Ganciclovir for the treatment and suppression of serious infections caused by cytomegalovirusO L Laskin, D M Cederberg, J Mills, et al.
[Zasshi] [Journal]. Nihon Kyobu Geka Gakkai|May 1, 1991
Thoracic surgery in the AIDS patientE J Beattie, S Guy, P Villamena, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 16, 2004
Changes in weight and lean body mass during highly active antiretroviral therapyC M Shikuma, R Zackin, F Sattler, et al.
Advances in Experimental Medicine and Biology|January 1, 1985
Longitudinal assessment of persistent generalized lymphadenopathy (PGL) in homosexual menU Mathur-Wagh, D Mildvan, I Spigland, et al.
Pageof 9

Showing results (41-50 of 86) with videos related to

Sort By:
Pageof 9
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 1, 1995
Predictors and outcome of multidrug-resistant tuberculosisN Salomon, D C Perlman, P Friedmann, et al.
Ophthalmology|July 1, 1987
Combined short- and long-term therapy for the treatment of cytomegalovirus retinitis using ganciclovir (BW B759U)J Orellana, S A Teich, A H Friedman, et al.
The New England Journal of Medicine|May 29, 1986
Toxic keratopathy associated with suramin therapyS A Teich, S Handwerger, U Mathur-Wagh, et al.
Journal of Clinical Immunology|March 1, 1997
Concentrations of soluble CD95 and CD8 antigens in the plasma and levels of CD8+CD95+, CD8+CD38+, and CD4+CD95+ T cells are markers for HIV-1 infection and clinical statusJ D Jiang, M Schlesinger, H Sacks, et al.
Lancet (London, England)|February 11, 1984
Iron and iron binding proteins in persistent generalised lymphadenopathy and AIDSB S Blumberg, H W Hann, D Mildvan, et al.
Lancet (London, England)|July 2, 1983
Increased frequency of HLA-DR5 in lymphadenopathy stage of AIDSR W Enlow, A Nunez Roldan, P LoGalbo, et al.
The American Journal of Medicine|August 1, 1987
Ganciclovir for the treatment and suppression of serious infections caused by cytomegalovirusO L Laskin, D M Cederberg, J Mills, et al.
[Zasshi] [Journal]. Nihon Kyobu Geka Gakkai|May 1, 1991
Thoracic surgery in the AIDS patientE J Beattie, S Guy, P Villamena, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 16, 2004
Changes in weight and lean body mass during highly active antiretroviral therapyC M Shikuma, R Zackin, F Sattler, et al.
Advances in Experimental Medicine and Biology|January 1, 1985
Longitudinal assessment of persistent generalized lymphadenopathy (PGL) in homosexual menU Mathur-Wagh, D Mildvan, I Spigland, et al.
Pageof 9